IP Library Granted Patent US 7,919,618
Granted Patent B2
US 7,919,618 · App. 11/832,738 · Granted Apr 5, 2011

Synthesis of piperazines, piperidines and related compounds

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,919,618
App. No.
11/832,738
Granted
Apr 5, 2011
Kind
B2
Abstract

Novel methods of synthesizing piperazines, piperidines and related compounds are disclosed, as are compounds useful for their preparation.

Claims (41)

1. A method of preparing a compound of formula I:

or a salt thereof, which comprises contacting a compound of formula IV with a compound of formula V:

under conditions sufficient for the formation of the compound of formula I, wherein:

Y-Z is C(O), O, CHOH or CH 2 ;

each E is independently N or CH;

each R 1 is independently fluorine, chlorine or optionally substituted alkyl, aryl, or aralkyl;

R 2 is H or ═O;

each R 3 is independently hydrogen, alkyl, aryl, aralkyl, heterocycle, or heterocycloalkyl;

m is 1, 2 or 3;

n is 1 or 2;

p is 1 or 2; and

q is 1-3.

2. The method of claim 1 , wherein the conditions sufficient for the formation of the compound of formula I are basic conditions.

3. The method of claim 1 , wherein the compound of formula IV is prepared by contacting a compound of formula II and a compound of formula III

with a transition metal catalyst under conditions sufficient for the formation of the compound of formula IV, wherein X is Br or I.

4. The method of claim 3 , wherein the catalyst is a palladium catalyst.

5. The method of claim 4 , wherein the catalyst comprises encapsulated or polymer-bound palladium.

6. The method of claim 4 , wherein the catalyst is bis(triphenylphosphine)palladium(II) dichloride.

7. The method of claim 3 , wherein the catalyst is present in an amount of from about 0.1 to about 7.5 mol percent.

8. The method of claim 1 , wherein Y—Z is C(O).

9. The method of claim 1 , wherein each E is CH.

10. The method of claim 1 , wherein p is 1 and R 1 is chlorine.

11. The method of claim 1 , wherein n and m are both 2.

12. The method of claim 3 , wherein Y—Z is C(O).

13. The method of claim 3 , wherein each E is CH.

14. The method of claim 3 , wherein p is 1 and R 1 is chlorine.

15. The method of claim 3 , wherein n and m are both 2.

16. The method of claim 3 , wherein the compounds of formulae II and III are in solution.

17. The method of claim 16 , wherein the solution comprises an alcohol.

18. The method of claim 3 , wherein the compound of formula IV is extracted using an aqueous acidic solution.

19. The method of claim 18 , wherein the solution comprises lactic acid.

20. The method of claim 3 , wherein the compound of formula IV is isolated as a salt.

21. The method of claim 20 , wherein the salt is a hydrochloride or phosphate salt.

22. A method of preparing (3′-chloro-biphenyl-4-yl)-(1-pyrimidin-2-yl-piperidin-4-yl)-methanone, or a salt thereof, which comprises contacting (3′-chloro-biphenyl-4-yl)-piperidine-4-yl-methanone with 2-chloropyrimidine under conditions sufficient for the formation of (3′-chloro-biphenyl-4-yl)-(1-pyrimidin-2-yl-piperidin-4-yl)-methanone.

23. The method of claim 22 , wherein the conditions sufficient for the formation of (3′-chloro-biphenyl-4-yl)-(1-pyrimidin-2-yl-piperidin-4-yl)-methanone are basic conditions.

24. A method of preparing (3′-chloro-biphenyl-4-yl)-piperidine-4-yl-methanone or a salt thereof, which comprises contacting 3-chlorophenyl boronic acid and (4-bromophenyl)(piperidine-4-yl)methanone with a transition metal catalyst under conditions sufficient for the formation of 3′-chloro-biphenyl-4-yl)-piperidine-4-yl-methanone.

25. The method of claim 24 , wherein the catalyst is a palladium catalyst.

26. The method of claim 25 , wherein the catalyst comprises encapsulated or polymer-bound palladium.

27. The method of claim 25 , wherein the catalyst is bis(triphenylphosphine)palladium(II) dichloride.

28. The method of claim 25 , wherein the catalyst is present in an amount of from about 0.1 to about 7.5 mol percent.

29. The method of claim 28 , wherein the catalyst is present in an amount of about 0.5 mol percent.

Assignments (5)
RELEASE OF SECURITY INTEREST Recorded May 5, 2026
From: OXFORD FINANCE LLC
To: LEXICON PHARMACEUTICALS, INC.; LEXICON PHARMACEUTICALS
Reel/Frame 075545/0601 →
SECURITY INTEREST Recorded Mar 17, 2022
From: LEXICON PHARMACEUTICALS, INC.
To: OXFORD FINANCE LLC, AS COLLATERAL AGENT
Reel/Frame 059432/0709 →
RELEASE OF SECURITY INTEREST Recorded Sep 14, 2020
From: BIOPHARMA CREDIT PLC
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 053767/0445 →
SECURITY INTEREST Recorded Dec 20, 2017
From: LEXICON PHARMACEUTICALS, INC.
To: BIOPHARMA CREDIT PLC
Reel/Frame 044958/0377 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 14, 2007
From: BURGOON, HUGH ALFRED; KANAMARLAPUDI, RAMANAIAH C; WU, WENXUE
To: LEXICON PHARMACEUTICALS, INC.
Reel/Frame 019827/0784 →